Home > Financial Ratios > STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE
EV/Core EBITDA

    Back to All Ratios
STRIDES PHARMA SCIENCE is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for STRIDES PHARMA SCIENCE
Please provide your vote to see the results

STRIDES PHARMA SCIENCE Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 9.399.0815.149.6951.09

What is the latest EV/Core EBITDA ratio of STRIDES PHARMA SCIENCE ?

The latest EV/Core EBITDA ratio of STRIDES PHARMA SCIENCE is 9.39 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar20269.39
Mar20259.08
Mar202415.14
Mar20239.69
Mar202251.09

How is EV/Core EBITDA of STRIDES PHARMA SCIENCE Trending?

Years EV/Core EBITDA % Change
Mar2026 9.39
3.41
Mar2025 9.08
-40.03
Mar2024 15.14
56.24
Mar2023 9.69
-81.03
Mar2022 51.09 -

Other Financial Ratios of STRIDES PHARMA SCIENCE


Compare EV/Core EBITDA ratio of peers of STRIDES PHARMA SCIENCE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE ₹9,626.6 Cr -4.7% -12.2% 24.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,283.0 Cr 0.1% -5% 5.4% Stock Analytics
DIVIS LABORATORIES ₹244,762.0 Cr -1.7% 0.2% 39.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,448.0 Cr -2.5% -5.5% 30.2% Stock Analytics
CIPLA ₹107,043.0 Cr 0.9% -2.6% -14.6% Stock Analytics
DR REDDYS LABORATORIES ₹102,820.0 Cr 0.1% 7.6% -3.5% Stock Analytics


STRIDES PHARMA SCIENCE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE

-4.7%

-12.2%

24.9%

SENSEX

3.1%

1%

-9.1%


You may also like the below Video Courses